Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aizea 75microgram tablets
0703021Q0BEAAAA
|
Aizea | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Ajovy 225mg/1.5ml solution for injection pre-filled pens
0407042R0BBABAB
|
Ajovy | Fremanezumab | Central Nervous System | No data available |
|
Ajovy 225mg/1.5ml solution for injection pre-filled syringes
0407042R0BBAAAA
|
Ajovy | Fremanezumab | Central Nervous System | No data available |
|
Akineton 2mg tablets
0409020G0BBAAAC
|
Akineton (Oral) | Biperiden hydrochloride | Central Nervous System | No data available |
|
Akis 75mg/1ml solution for injection ampoules
1001010C0CQAABM
|
Akis | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Aknemin 100mg capsules
0501030P0BDABAE
|
Aknemin | Minocycline hydrochloride | Infections | No data available |
|
Aknemin 50 capsules
0501030P0BDAAAD
|
Aknemin | Minocycline hydrochloride | Infections | No data available |
|
Aknicare SR skin roller
21350000102
|
Aknicare SR skin roller | Acne Treatment | Appliances | No data available |
|
Akynzeo 300mg/0.5mg capsules
0406000AGBBAAAA
|
Akynzeo | Netupitant/palonosetron hydrochloride | Central Nervous System | No data available |
|
Alanine powder
0913445A0AAABAB
|
Pdr disc/non ACBS single L-amino acid supplement (0913445) | Pdr disc/non ACBS single L-amino acid supplement (0913445) | Nutrition and Blood | No data available |
|
Alateris 625mg tablets
1001050A0BBAAAA
|
Alateris | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Alba 20% solution for infusion 100ml bottles
0902022A0BDACAC
|
Alba | Albumin solution | Nutrition and Blood | No data available |
|
Alba 4.5% solution for infusion 100ml bottles
0902022A0BDAAAE
|
Alba | Albumin solution | Nutrition and Blood | No data available |
|
Alba 4.5% solution for infusion 400ml bottles
0902022A0BDABAI
|
Alba | Albumin solution | Nutrition and Blood | No data available |
|
Albiglutide 30mg inj pre-filled disposable devices
0601023ASAAAAAA
|
Albiglutide | Albiglutide | Endocrine System | No data available |
|
Albiglutide 50mg inj pre-filled disposable devices
0601023ASAAABAB
|
Albiglutide | Albiglutide | Endocrine System | No data available |
|
Albufilm tape 1.25cm
20100000580
|
Albufilm tape 1.25cm | Surgical Adhesive Tape | Dressings | No data available |
|
Albufilm tape 2.5cm
20100000581
|
Albufilm tape 2.5cm | Surgical Adhesive Tape | Dressings | No data available |
|
Albufilm tape 5cm
20100000582
|
Albufilm tape 5cm | Surgical Adhesive Tape | Dressings | No data available |
|
Albumin human 20% solution for infusion 100ml bottles
0902022A0AAACAC
|
Human albumin | Albumin solution | Nutrition and Blood | No data available |
|
Albumin human 20% solution for infusion 50ml bottles
0902022A0AAABAB
|
Human albumin | Albumin solution | Nutrition and Blood | No data available |
|
Albumin human 4.5% solution for infusion 100ml bottles
0902022A0AAAEAE
|
Human albumin | Albumin solution | Nutrition and Blood | No data available |
|
Albumin human 4.5% solution for infusion 250ml bottles
0902022A0AAAFAF
|
Human albumin | Albumin solution | Nutrition and Blood | No data available |
|
Albumin human 4.5% solution for infusion 400ml bottles
0902022A0AAAIAI
|
Human albumin | Albumin solution | Nutrition and Blood | No data available |
|
Albumin human 4.5% solution for infusion 500ml bottles
0902022A0AAAGAG
|
Human albumin | Albumin solution | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.